date:Jul 21, 2012
s the outcome of many years of research and clinical studies into ways of preserving cocoa flavanols and establishing their health benefits.
This opinion will not open up the floodgates but will encourage our industry to pursue its innovation efforts and researches,she said.
Building its case
Barry Callebaut obtained the EFSA nod based upon five published and one unpublished randomised controlled trials.
The EFSA panel considered one studyfrom Davisonet al.from 2008 involving 65 participants